Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The future of antibiotics and resistance.

Literature DB >> 23343059

The future of antibiotics and resistance.

Brad Spellberg¹, John G Bartlett, David N Gilbert.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Anti-Bacterial Agents

Year: 2013 PMID： 23343059 PMCID： PMC3617123 DOI： 10.1056/NEJMp1215093

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

× No keyword cloud information.

4 in total

1. White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens.

Authors:
Journal: Clin Infect Dis Date: 2012-08-13 Impact factor: 9.079

2. Antibiotic resistance is prevalent in an isolated cave microbiome.

Authors: Kirandeep Bhullar; Nicholas Waglechner; Andrew Pawlowski; Kalinka Koteva; Eric D Banks; Michael D Johnston; Hazel A Barton; Gerard D Wright
Journal: PLoS One Date: 2012-04-11 Impact factor: 3.240

3. Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis.

Authors: Lin Lin; Brandon Tan; Paul Pantapalangkoor; Tiffany Ho; Beverlie Baquir; Andrew Tomaras; Justin I Montgomery; Usa Reilly; Elsa G Barbacci; Kristine Hujer; Robert A Bonomo; Lucia Fernandez; Robert E W Hancock; Mark D Adams; Samuel W French; Virgil S Buslon; Brad Spellberg
Journal: MBio Date: 2012-10-02 Impact factor: 7.867

Review 4. The damage-response framework of microbial pathogenesis.

Authors: Arturo Casadevall; Liise-anne Pirofski
Journal: Nat Rev Microbiol Date: 2003-10 Impact factor: 60.633

4 in total

164 in total

Review 1. Important Complexities of the Antivirulence Target Paradigm: A Novel Ostensibly Resistance-Avoiding Approach for Treating Infections.

Authors: Thomas A Russo; Brad Spellberg; James R Johnson
Journal: J Infect Dis Date: 2015-11-12 Impact factor: 5.226

2. The FDA reboot of antibiotic development.

Authors: David M Shlaes; Dan Sahm; Carol Opiela; Brad Spellberg
Journal: Antimicrob Agents Chemother Date: 2013-07-29 Impact factor: 5.191

3. Multiple broad-spectrum Beta-lactamase targets for comprehensive surveillance.

Authors: Kathy A Mangold; Barbara L Voss; Kamaljit Singh; Richard B Thomson; Donna M Schora; Lance R Peterson; Karen L Kaul
Journal: J Clin Microbiol Date: 2013-08-07 Impact factor: 5.948

4. Comparison of sputum and nasopharyngeal aspirate samples and of the PCR gene targets lytA and Spn9802 for quantitative PCR for rapid detection of pneumococcal pneumonia.

Authors: Kristoffer Strålin; Björn Herrmann; Guma Abdeldaim; Per Olcén; Hans Holmberg; Paula Mölling
Journal: J Clin Microbiol Date: 2013-10-23 Impact factor: 5.948

5. Penetration of GSK1322322 into epithelial lining fluid and alveolar macrophages as determined by bronchoalveolar lavage.

Authors: Odin J Naderer; Keith A Rodvold; Lori S Jones; John Z Zhu; Chester L Bowen; Liangfu Chen; Etienne Dumont
Journal: Antimicrob Agents Chemother Date: 2013-11-04 Impact factor: 5.191

6. Predominance of Lactobacillus spp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms.

Authors: Rafael Araos; Albert K Tai; Graham M Snyder; Martin J Blaser; Erika M C D'Agata
Journal: Clin Infect Dis Date: 2016-06-28 Impact factor: 9.079

7. ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation.

Authors: Seth M Daly; Bradley O Elmore; Jeffrey S Kavanaugh; Kathleen D Triplett; Mario Figueroa; Huzefa A Raja; Tamam El-Elimat; Heidi A Crosby; Jon K Femling; Nadja B Cech; Alexander R Horswill; Nicholas H Oberlies; Pamela R Hall
Journal: Antimicrob Agents Chemother Date: 2015-02-02 Impact factor: 5.191